Tenaya Therapeutics, Inc.
TNYA
$1.41
$0.1511.94%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 13.33% | -12.70% | 7.01% | 12.90% | 8.68% |
| Total Depreciation and Amortization | -21.68% | 27.38% | -0.57% | -1.04% | -1.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.17% | 2.98% | -12.35% | -10.94% | 11.44% |
| Change in Net Operating Assets | 129.32% | -231.56% | 21.34% | 32.08% | 46.72% |
| Cash from Operations | 32.45% | -25.69% | 7.30% | 16.01% | 17.60% |
| Capital Expenditure | 62.92% | -87.75% | -10.87% | -152.05% | 87.06% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 10.78% | 58.56% | 147.83% | -237.93% | 652.56% |
| Cash from Investing | 12.04% | 58.14% | 146.86% | -239.25% | 581.51% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 13,231.30% | 1,116.13% | -94.56% | -98.78% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.95% | 13,231.30% | 1,116.13% | -94.56% | -98.78% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -82.00% | 1,365.33% | 92.17% | -3,384.85% | -110.51% |